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The calcium-binding, vertebrate-specific S100 protein family consists of 20
paralogs in humans (referred as the S100ome), with several clinically
important members. To explore their protein–protein interactions (PPIs)
quantitatively, we have chosen an unbiased, high-throughput, competitive
fluorescence polarization (FP) assay that revealed a partial functional
redundancy when the complete S100ome (n = 20) was tested against
numerous model partners (n = 13). Based on their specificity, the S100ome
can be grouped into two distinct classes: promiscuous and orphan. In the
first group, members bound to several ligands (> 4–5) with comparable
high affinity, while in the second one, the paralogs bound only one partner
weakly, or no ligand was identified. Our results demonstrate that FP assays
are highly suitable for quantitative interaction profiling of selected protein
families. Moreover, we provide evidence that PPI-based phenotypic charac-
terization can complement or even exceed the information obtained from
the sequence-based phylogenetic analysis of the S100ome, an evolutionary
young protein family.
Introduction
Biochemical characterization of protein–protein inter-
actions (PPIs) is a challenging field in molecular life
sciences, which is usually limited to the determination
of steady-state dissociation constants [1]. The accurate
determination of thermodynamic parameters of molec-
ular interactions is performed by fast, but superficial,
high-throughput (HTP) methods. In the literature,
several HTP approaches are applied such as
coimmunoprecipitation [2], yeast two-hybrid and spot
assays [3], pull-down assay [4], holdup assay [5], and
direct fluorescence polarization/anisotropy [6]. In
direct fluorescence polarization (FP) experiments, a
fluorescent probe (usually a labeled peptide) is titrated
with a globular partner. Their association is monitored
by the polarization of the emitted light of the fluo-
rophore (Fig. 1A). In a modified FP experiment called
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competitive assay, both the probe and partner concen-
tration are fixed, and the reaction mixture is titrated
with an unlabeled competitor molecule (peptide or
protein). Depolarization of the emitted light is indica-
tive of the competition between the probe and the
competitor in binding to the partner (Fig. 1B,C).
While direct FP can be perturbed by the presence of
the fluorescent dye, the competitive assay is unbiased
and therefore more suitable for accurate HTP mea-
surements of dissociation constants [7,8].
S100 proteins belong to the superfamily of EF-hand
containing calcium-binding proteins. They appeared in
early vertebrates and consist of 20 core paralogs in the
human proteome [9]. S100s are associated with several
disease conditions, such as cardiomyopathies, cancer,
and inflammatory and neurodegenerative diseases, in
which their overexpression can be observed in the
affected cells [10–12]. Due to this reason, they are
emerging biomarkers and also promising therapeutic
targets [13]. Despite their growing importance, the lit-
erature still lacks their comprehensive and systematic
analysis, which would be essential for developing
rational strategies for drug development. Similar to
calmodulin, they can interact with protein or peptide
targets in a calcium-dependent manner [14]. They are
generally considered as relatively low specificity pro-
teins, with dozens of interaction partners, among them
they are unable to maintain high selectivity [15]. In
this study, we determined the interaction profile of the
full human S100 family (termed here as the S100ome)
against a set of diverse known S100 partners (and
some of their paralogs) systematically, including
kinases such as RSK1 [16] and its paralogs MK2 and
MNK1; cytoskeletal elements such as CapZ [17] (com-
monly known as TRTK12), NMIIA [18], ezrin [19],
FOR20 and its paralog FOP [20]; membrane proteins
such as NCX1 [15] and TRPM4 [21]; and other signal-
ing proteins such as the tumor suppressor p53 [22–24],
SIP [15], and MDM4 [23].
Results
Mapping the S100ome with FP measurements
The interactions between S100 homodimers and their
selected labeled peptide partners were studied first by
direct FP assay (Figs S1–S13). We have found that all
reasonable S100 interactions gave an experimental
window of 50–200 mP (polarization). If significant
binding was detected (Kd < 200 µM) between a labeled
peptide and an S100 protein, a subsequent competitive
FP assay was performed. In cases, where no labeled
peptide was available (e.g., when globular protein
domains were used as competitors), we used noncog-
nate tracers against all possible S100 proteins. Addi-
tionally, we tested the possible binding between these
competitors and the noncognate probes in direct FP
experiments to eliminate the possibility of rebinding
(Fig. S14). This way, we tested 180 unique direct and
150 unique competitive interactions and found 89 and
Fig. 1. The theory of fluorescence polarization assays. (A) Fluorescence polarization/anisotropy experiments can be performed with direct
and competitive titrations. In direct assay (direct titration, (d)), the concentration of the protein of interest is increased in the presence of
tracer amount of labeled peptide. Upon complex formation, the hydrodynamic radius of the tracer increases causing slower rotation and
therefore lower depolarization of the emitted light. In the direct assay, one can measure the minimal and maximal polarization values, a
dissociation constant, and importantly, an optimal concentration can be easily determined for competitive assays, which is usually the
concentration corresponding to 60–80% saturation. (B) In a competitive assay (competitive titration, (c)), the concentration of the protein of
interest is set to this concentration and one can titrate the reaction mixture with a competitor. The competition results in increased level of
free labeled peptide and consequently high depolarization of the emitted light. (C) Competitive FP is not affected by the presence of a
labeling group in the peptide (unbiased) and has a high dynamic range (approximately two orders of magnitudes around the dissociation
constant of the probe). At high concentrations, it can be also used to determine the stoichiometry of the interaction for strong interactions.
Kd(d) and Kd(c) correspond to direct and competitive dissociation constants, respectively. The red and blue graphs (on panel C) correspond
to two scenarios, in which the competitive Kd (Kd(c)) is 10-fold higher and 10-fold lower than the direct Kd (Kd(d)), respectively.
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66 significant interactions, respectively (Table 1,
Figs S1–S13).
Compared to the direct assay, competitive FP pro-
vides unbiased (or more specific) affinities, unaffected
by the chemical labeling, making it a better tool to
measure protein–protein interactions (Fig. 2A,B).
Nevertheless, there are some pitfalls (Fig. 2), which
should be taken into consideration while analyzing
competitive data. First of all, the experimental win-
dow of the competitive measurement should be the
same as the experimental window of the direct mea-
surement (Fig. 2C). Studying large biomolecules
(e.g., globular proteins) in a competitive experiment
often results in an increased base polarization (Pmin)
due to the change in biophysical properties of the
reaction mixture (e.g., change in viscosity). More-
over, during a competition experiment, it is possible
that the competitor can interact with the probe
itself, which can also cause an increase in the base
polarization (Fig. S14). In rare cases, saturation
polarization can be also altered (e.g., due to
oligomerization at higher concentration). Addition-
ally, experimental artifacts of unknown origin can be
observed occasionally (Fig. 2D). Here, a sharp
decline can be detected during the titration, which
results in an IC50 value smaller than the fixed
Table 1. Quantitative characterization of interactions between S100 proteins and their selected partners by FP (N.D., not determined; E.A.,
experimental artifact; (d), direct titration; (c), competitive titration).
Kd (lM)
fp53 (d) p53 (c) fNMIIA (d) NMIIA (c) fCapZ (d) CapZ (c) fNCX1 (d) NCX1 (c) fSIP (d) SIP (c) FOR20 (c)
S100A1 41  11 > 200 0.033  0.0062 0.004  0.001 8.9  2.0 5.2  1.7 2.6  0.14 2.6  0.56 > 200 N.D. 0.50  0.25
S100A2 2.9  0.08 5.2  0.39 0.057  0.0038 0.013  0.0022 > 200 N.D. 5.5  0.37 > 200 102  40 > 200 0.27  0.03
S100A3 7.6  0.44 7.7  1.9 5.5  1.0 E.A. > 200 N.D. 25  2.5 > 200 > 200 N.D. 29  5.6
S100A4 0.85  0.04 2.1  0.23 0.026  0.0065 0.0088  0.0025 > 200 N.D. 15  0.62 > 200 42  5.2 11  2.7 2.0  0.20
S100A5 26  2.4 67  23 5.8  0.67 2.9  0.51 4.7  0.28 5.4  0.84 4.6  0.22 5.2  1.1 42  3.2 40  7.8 1.9  0.53
S100A6 0.68  0.020 2.2  0.090 0.58  0.07 0.21  0.04 > 200 N.D. 27  1.8 > 200 8.7  0.48 20  1.1 0.007  0.0018
S100A7 > 200 N.D. 13.1  1.4 E.A. > 200 N.D. 30  2.1 E.A. > 200 N.D. 5.9  0.54
S100A8 > 200 N.D. > 200 N.D. > 200 N.D. 56  5.0 E.A. > 200 N.D. > 200
S100A9 > 200 N.D. > 200 N.D. > 200 N.D. 20  3.2 > 200 > 200 N.D. > 200
S100A10 48  2.9 > 200 > 200 N.D. > 200 N.D. 53  6.6 > 200 > 200 N.D. > 200
S100A11 10  0.72 12  2.4 49  14 E.A. > 200 N.D. 52  2.9 E.A. > 200 N.D. > 200
S100A12 76  11 N.D. > 200 N.D. > 200 N.D. 170  63 E.A. > 200 N.D. > 200
S100A13 35  10 > 200 > 200 N.D. > 200 N.D. 87  14 E.A. > 200 N.D. > 200
S100A14 > 200 N.D. 98  127 E.A. > 200 N.D. 71  7.5 E.A. > 200 N.D. 63  30
S100A15 > 200 N.D. 17  1.5 E.A. > 200 N.D. 28  3.4 E.A. > 200 N.D. 17  2.1
S100A16 79  8.9 N.D. > 200 N.D. > 200 N.D. > 200 N.D. > 200 N.D. > 200
S100B 33  3.2 > 200 4.7  0.25 2.9  0.31 2.3  0.13 1.8  0.23 7.7  0.95 > 200 > 200 N.D. 0.25  0.050
S100G > 200 N.D. 21  1.9 E.A. > 200 N.D. 24  1.7 E.A. > 200 N.D. 3.8  1.1
S100P 0.17  0.01 0.54  0.040 0.99  0.11 0.14  0.03 11  1.4 4.1  0.73 4.0  0.23 > 200 38  3.2 > 200 1.2  0.13
S100Z > 200 N.D. > 200 N.D. > 200 N.D. 11  0.45 E.A. > 200 N.D. > 200
Kd (lM)






(c) MK2 (c) MNK1 (c) FOP (c)
S100A1 0.38  0.061 > 200 91  14 35  10 > 200 N.D. 4.8  0.72 > 200 15  4.6 > 200 0.35  0.14
S100A2 1.0  0.062 1.1  0.23 49  10 53  16 15  0.62 5.4  0.57 5.1  0.53 > 200 4.5  1.0 18  4.2 0.081  0.019
S100A3 0.91  0.052 3.4  0.45 > 200 N.D. > 200 N.D. > 200 N.D. > 200 > 200 0.27  0.13
S100A4 5.9  0.36 35  113 > 200 N.D. 11  0.73 6.1  0.80 8.5  0.89 > 200 > 200 24  3.5 0.048  0.010
S100A5 0.60  0.051 2.3  0.71 61  5.4 65  7.5 > 200 N.D. > 200 N.D. > 200 > 200 0.56  0.20
S100A6 1.4  0.081 8.4  2.0 > 200 N.D. > 200 N.D. 8.7  0.81 > 200 > 200 6.7  0.53 0.0056  0.0050
S100A7 > 200 N.D. > 200 N.D. > 200 N.D. > 200 N.D. E.A. E.A. > 200
S100A8 3.8  0.57 13  4.4 > 200 N.D. > 200 N.D. > 200 N.D. N.D. > 200 > 200
S100A9 21  7.3 > 200 > 200 N.D. > 200 N.D. > 200 N.D. N.D. > 200 > 200
S100A10 17  1.9 125  25 > 200 N.D. > 200 N.D. > 200 N.D. > 200 > 200 > 200
S100A11 2.4  0.12 106  11 > 200 N.D. > 200 N.D. > 200 N.D. > 200 > 200 > 200
S100A12 > 200 N.D. > 200 N.D. > 200 N.D. > 200 N.D. N.D. > 200 > 200
S100A13 > 200 N.D. > 200 N.D. > 200 N.D. > 200 N.D. N.D. N.D. > 200
S100A14 12  5.6 > 200 > 200 N.D. > 200 N.D. > 200 N.D. E.A. E.A. > 200
S100A15 > 200 N.D. > 200 N.D. > 200 N.D. > 200 N.D. E.A. E.A. > 200
S100A16 > 200 N.D. > 200 N.D. > 200 N.D. > 200 N.D. N.D. > 200 > 200
S100B 16  25 > 200 0.20  0.04 0.15  0.04 > 200 N.D. 2.8  0.47 1.2  0.86 3.2  0.73 > 200 1.2  0.53
S100G > 200 N.D. > 200 N.D. > 200 N.D. > 200 N.D. E.A. E.A. > 200
S100P 0.93  0.24 > 200 > 200 N.D. > 200 N.D. 4.5  0.47 > 200 2.7  0.47 2.5  0.38 0.066  0.0049
S100Z > 200 N.D. > 200 N.D. > 200 N.D. > 200 N.D. N.D. N.D. > 200
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receptor concentration. This observed substoichiomet-
ric complex formation should be handled with extra
care as it is likely due to unexpected biophysical
phenomena, such as protein aggregation. To stan-
dardize and automatize data handling and to elimi-
nate subjective factors, we developed a Python-based
universal program, called ProFit, for fitting all direct
and competitive experimental data (freely available
at https://github.com/GoglG/ProFit).
Validation with ITC measurements
The biochemically described S100 binding motifs,
found in the literature, show an extremely low
Fig. 2. Possible outcomes of a competitive experiment. (A) In ‘perfect experiments’, the experimental window is stable and the dissociation
constants match between the (cognate) probe and the competitor. (B) As often occurs, fluorescent labeling can alter the binding affinity,
resulting in false-positive interaction partners in direct FP experiments. In other cases, the effect is softer and it only causes a dimming
effect on the biochemical constant. (C) The reliable experimental window can be different in a competitive experiment. If the change is not
extreme, the competitive Kd can be considered (with caution) as the relevant biochemical constant. (D) In some cases, a rapid decline can
be observed in the polarization. In this case, the experimentally determined IC50 value should not be used as a dissociation constant. This
phenomenon can be explained by a competitor-induced biophysical transition, for example, aggregation or precipitation. In this final case, it
is very important to redetermine the concentrations of the receptor and the competitor and to repeat the experiment at different receptor
concentrations to properly discriminate the stoichiometric molar ratio from the observed IC50 value.
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sequence similarity [15,23] (Fig. 3A). Mostly, linear
segments are recognized by the human S100ome; how-
ever, no consensus S100 binding sequence can be
defined [15]. In general, hydrophobic residues are pre-
ferred, but additional basic residues can also be
favored in some instances. Moreover, S100 proteins
can form two types of complexes (Fig. 3B). Earlier
studies showed that a symmetric S100 dimer can rec-
ognize two identical binding motifs (1 S100 dimer
binds 2 partners, N = 1), symmetrically [17,25,26]. In
recent studies, however, several asymmetric complexes
(1 S100 dimer binds 1 partner, N = 0.5) were also
described [18,27,28]. In those cases, an S100 dimer
captures a single partner at the two binding sites. As
the binding affinity highly depends on the stoichiome-
try of the interaction, we selected a set of significant,
peptide-based interactions for isothermal titration
calorimetric (ITC) measurements. This way, we vali-
dated the interactions that were originally detected by
the FP assay and determined the binding stoichiometry
in all instances.
All determined Kd values correlated well with the
data provided by the orthogonal FP measurements
(Table 2, Fig. S15). Symmetric interactions were found
with CapZ, NCX1, SIP, TRPM4, and MDM4. In
cases of CapZ and MDM4, the experimental data were
fitted by a two binding site model indicating slightly
different affinities and a complex relationship between
the S100 monomers. In contrast, asymmetrical interac-
tions were detected with p53, RSK1, C-ERMAD,
NMIIA, and FOP. These findings confirmed the
expected binding stoichiometry in all cases and clari-
fied the binding mode of TRPM4 and FOP. We
hypothesize that the binding mode of close paralogs
should be identical (symmetric or asymmetric); there-
fore, asymmetric binding was assumed for MNK1,
MK2 (based on RSK1), and FOR20 (based on FOP).
We performed these ITC measurements in parallel
with the FP experiments, and based on the refined sto-
ichiometry, monomer or dimer S100 concentrations
were used during the FP data evaluation.
Specificity map of the S100ome
The 20 S100 paralogs, whose interactions were studied
here, represent almost the complete human S100ome
[13]. It is a chordata-specific, evolutionary young pro-
tein family, and despite the fact that they exhibit mod-
erate sequence similarity, they are structurally very
similar owing to their small size (~ 100 residues) and
conserved fold (including two consecutive EF-hand
motifs) (Fig. 4A). Due to this reason, their phyloge-
netic analysis generally does not lead to unambiguous
results [29,30]. Applying different parameters during
the analyses resulted in varied grouping of the human
S100ome; moreover, only a few clades received statisti-
cal supports (see our analyses in Fig. 4B). Because of
these ambiguities of the phylogenetic analyses, a phe-
notypic screening and analysis could provide a more
reliable grouping and could reveal functional similari-
ties among the paralogs of the protein family of inter-
est beside the sequence-based genealogies. For such
purpose, we decided to create a robust phenogram
[31], representing the functional relationships within
the human S100ome, using hierarchical clustering
(UPGMA) [32]. This analysis separated the S100ome
into two groups, in which the first group contains
S100 proteins generally lacking significant interactions
(termed here as ‘orphan’ S100 proteins) and the second
group comprises generally good binders (termed here
as ‘promiscuous’ S100 proteins) (Fig. 5). While
promiscuous S100 proteins showed significant binding
Fig. 3. The S100 protein family. (A) Multiple short linear motifs are recognized by S100 family members; however, no consensus-binding motif
can be defined for the protein family, as indicated here by the sequence alignment of several S100 binding motifs by ClustalW algorithm
(UniProt accession codes: CapZ: P52907, MDM4: O15151, NCX1: P32418, C-ERMAD: P15311, FOP: O95684, FOR20: Q96NB1, TRPM4:
Q8TD43, NMIIA: P35579, p53: P04637, SIP: Q9HB71, RSK1: Q15418). Though it is noteworthy that hydrophobic residues (green) are
preferred, basic residues are also welcome in some cases. (B) S100 proteins act as dimers and are capable of interacting in two distinct ways
with other proteins. On the left, a symmetric complex is shown, where one S100 dimer interacts with two peptides (S100B-CapZ, PDB code:
1MWN, [17]). By contrast, a single interacting partner can bind to one S100 dimer asymmetrically, as it is shown on the right side (S100A4-
NMIIA, PDB code: 3ZWH, [18]). PYMOL (Schr€odinger, New York, NY, USA) was used for visualization and for preparing molecular images.
5The FEBS Journal (2020) ª 2019 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of
Federation of European Biochemical Societies
M. A. Simon et al. The specificity map of S100 interactions
to at least a few (4–5) of the tested interaction part-
ners, orphan S100 proteins showed either no sign of
partner binding or a weak binding to a single partner.
Discussion
Competitive FP as a potent tool to measure high-
throughput macromolecular interactions
Although numerous HTP, semiquantitative approaches
are available and many low-throughput but highly
accurate methods exist to measure PPIs, reliable and
quantitative HTP methods are scarce in the literature.
On the one hand, direct FP assay can be performed in
large scale in multiwell plates, which makes it an ideal
method for rapid interaction screening; however, it has
the serious limitation of chemical labeling that can per-
turb the binding measurement. Competitive FP, on the
other hand, shares the same properties but without
any possible interference from the labeling dye. More-
over, it provides comparative results to other, orthogo-
nal, usually low-throughput, label-free biochemical
assays, such as ITC or SPR measurements [33]. In the
present work, we applied this robust HTP method to
characterize the specificity map of the S100 interac-
tome. We used minimal S100 binding segments (with a
few exceptions) due to technical and biochemical rea-
sons. On the one hand, this is a limitation, because the
presented affinities might be different in full-length
proteins, but on the other hand, the generated data set
remained as comparative as possible between different
S100 proteins. One should note that binding stoi-
chiometry and oligomerization of the investigate pro-
teins, in this case, S100s, could affect the FP
measurements and data evaluation. As both properties
could affect the binding ratio and the affinity,
orthogonal measurements are important as part of the
validation process [34]. In summary, competitive FP
assay is robust and has HTP; thus, it is a valuable tool
for screening macromolecular interactions involving
linear peptide motifs, RNA/DNA oligonucleotides, or
fluorescent small molecules [35,36].
Functional redundancy within the S100 family
and possible functions of the orphan group
S100 proteins are usually considered as ‘sticky’, rela-
tively low specificity proteins [15], which is also sup-
ported by several studies covering nearly all S100
proteins and only one or few S100 targets [20,37–41].
Usually, the tested S100 proteins only covered the
closest relatives (e.g., S100A2, S100A4, S100A6,
S100B, S100P), and the results often showed redun-
dant bindings [19,27,40,42,43]. In one study, close to
the full S100ome was tested against a simple peptide
(derived from CapZ), highlighting binding promiscuity
for a subset of S100 isoforms [38]. However, no sys-
tematic study has been performed to make a specificity
map involving the complete S100ome against multiple
S100 partners. Based on functional clustering, we have
revealed here that the S100ome can be separated into
two groups, which is comparable with previous find-
ings based on few partners. The minor group of eight
members includes promiscuous paralogs, which clearly
suggests functional redundancy, at least in vitro. How-
ever, this does not mean that they do not have specific
interactions (e.g., RSK1 is highly specific partner of
S100B) In contrast, the major group consists of 12
members without a clear binding preference. The func-
tion of this orphan group on the molecular level is less
defined. All the dimeric S100 proteins (with the excep-
tion of S100A10) are calcium sensors; however, if they






S100 subunit) Kd (lM) DH (kJmol1) TDS (kJmol1)
S100A6-FOP 310 0.44  0.002 Previously unknown 0.088  0.0073 73  0.58 31
S100B-CapZ 310 0.44  0.002 1 [17] 3.9  0.39 15  0.37 17
0.343  0.002 0.94  0.03 3.3  0.67 33
S100A1-NCX1 310 1.1  0.013 1 [15]a 6.4  0.58 35  0.80 4.0
S100A5-TRPM4 310 0.89  0.0037 Previously unknown 1.4  0.089 24  0.21 10
C-ERMAD-S100A4 310 0.52  0.015 0.47 [19] 18  2.7 49  3.0 22
S100A5-SIP 310 0.92  0.24 1 [26]a 21  20 4.1  2.5 24
S100A1-NMIIA 298 0.49  0.0017 0.5 [18]a 0.009  0.005 36  0.34 82
S100B-MDM4 310 0.52  0.039 1 [23] 0.71  0.036 186  142 150
0.53  0.038 0.63  0.081 111  148 148
a These interactions were measured with a different S100 paralog.
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have no additional interaction partners, which is diffi-
cult to prove, they could simply act as calcium buffers
(like S100Z) contributing to calcium homeostasis of
the cells [44]. Alternatively, and more likely, they can
have highly specific, yet undiscovered, interaction part-
ners. In this case, the orphan designation is only tem-
porary and reflects a limitation of our analysis. For
example, S100A10, the only S100 protein without a
functional EF-hand motif, can mediate a very high
affinity and rather specific interaction with annexin A2
[42]. It is still possible that there is functional redun-
dancy within the orphan group, but our knowledge
about S100 interaction partners is more limited in this
group compared to the promiscuous group as no
known interaction partners are available. Moreover,
the present study covered only S100 homodimers (and
the S100G monomer), although some S100 proteins
can form heterodimers [45]. As an example, the
S100A8/A9 (both coming from the orphan group) can
form a functional heterodimer with known interaction
partners [46].
Based on an interaction specificity map of the S100
proteins, we propose here that a more widespread
functional redundancy exists in the family than
Fig. 4. Phylogenetic map of the S100 protein family. (A) S100 proteins are small (~ 100 amino acids long) EF-hand proteins, sharing high
sequence identity (identical residues with S100A1 are shown in gray). The sequences were aligned by CLUSTALW algorithm (UniProt accession
codes: S100A1: P23297, S100A2: P29034, S100A3: P33764, S100A4: P26447, S100A5: P33763, S100A6: P06703, S100A7: P31151,
S100A8: P05109, S100A9: P06702, S100A10: P60903, S100A11: P31949, S100A12: P80511, S100A13: Q99584, S100A14: Q9HCY8,
S100A15: Q86SG5, S100A16: Q96FQ6, S100B: P04271, S100G: P29377, S100P: P25815, and S100Z: Q8WXG8). The fold consists of two
consecutive EF-hand motifs, connected by a hinge region. The calcium ions are coordinated by several residues between helices I–II and
III–IV (- highlighted with asterisks). (B) The affinity profile of S100ome is clustered by the phylogeny of the different S100 paralogs. For the
phylogenetic analyses, the human S100 paralog sequences were aligned by CLUSTALW, MUSCLE, and PRANK algorithms with default parameters
(see Materials and methods section). The evolutionary histories were inferred by maximum-likelihood method with 10 runs, using
ProtGamma and LG as substitution model and substitution matrix, respectively. The supports of the branches were tested by bootstrap
analysis (1000 replicates) shown as % (values below 60% are not shown). The analyses were conducted by RAXML GUI. It is shown that
S100A2/A3/A4/A5/A6 and S100A13/A14 can be considered as monophyletic groups, supported by high values (S100A7/A15 are almost
identical paralogs). Nevertheless, the phylogenetic analyses do not provide unambiguous genealogy for the rest of the S100 proteins.
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previously thought. Our results provide thermody-
namic evidence for possible complex formation with
minimal binding segments, and further studies are
needed to see whether individual complexes can be
indeed formed in a particular cell type and to test that
functional redundancy also exists in vivo. Regarding
the possible biological relevance, the hereby defined
functional redundancy can act as a potential compen-
satory mechanism under pathological conditions, in
which the expression patterns and levels of multiple
S100 proteins are altered [12].
Function-based examination of relationships
within the S100ome complements phylogenetic
analysis
The phylogenetic analyses of the human S100ome
resulted in rather ambiguous genealogies, likely due to
the young age of the protein family (Fig. 4B). Never-
theless, the clade including S100A2, S100A3, S100A4,
S100A5, and S100A6 was supported with high statisti-
cal values in all analyses (Fig. 4B) similarly as it had
also been found by others [29,30]. Our functional anal-
ysis has revealed that all members of this clade belong
to the same subset of the promiscuous group, with a
greatly similar functional profile. However, the phy-
logeny of the rest of the S100ome is supported with
lower statistical values. Therefore, we suggest that in
such scenarios, function-based phenotypic clustering
can complement or even exceed the information
obtained from pure sequence-based phylogenetic anal-
ysis [47]. In our case, the S100 family can be divided,
relatively unambiguously, into two bigger clusters
(Fig. 5), thus giving a more robust classification. Map-
ping the specificity and clustering of the S100ome con-
tribute to the better understanding of this vertebrate-
specific Ca2+-binding protein family. An implication
of the functional redundancy defined hereby is a possi-
bility that a function-based combinatorial theranostic
strategy may be more effective than detecting individ-
ual proteins of the S100 family.
Materials and methods
Expression and purification of S100 proteins
Protein preparations were done as described previously
[48]. Briefly, the cDNAs of S100 proteins were cloned into
a modified pET15b expression vector. All protein con-
structs were expressed in Escherichia coli BL21 (DE3) cells
(Novagen, Kenilworth, NJ, USA) with a tobacco etch virus
(TEV)-cleavable N-terminal His6-tag, and purified by Ni
2+
affinity chromatography. The His6-tag was cleaved by TEV
protease, which was followed by either hydrophobic
Fig. 5. The phenogenetic map of the S100
protein family. The determined dissociation
constants are depicted as a heatmap
representing the specificity map of the
S100ome. Hierarchical clustering, based on
functional relationships, divided the
S100ome into two different groups, one of
them consists of low(er) specificity and/or
more promiscuous S100 proteins
(‘promiscuous’), while the other one
contains high(er) specificity and/or less
promiscuous members of the family
(‘orphan’). White and gray fields indicate
nondetermined interactions and cases with
experimental artifacts, respectively.
Stoichiometry (2 mol peptides/2 mol S100
subunit, N = 1; 1 mol peptides/2 mol S100
subunit, N = 0.5) is also shown for all
ligands at the end of each rows.
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interaction chromatography, ion-exchange chromatogra-
phy, or size-exclusion chromatography with applying stan-
dard conditions [48]. The quality of the recombinant
proteins was checked by SDS/PAGE analysis.
Expression and purification of kinases
The kinase domains, RSK1-CTKD (411–735), MK2 (1–
400), and MNK1 (1–465), were cloned into a variant
pGEX expression vector. The kinase domains were
expressed in E. coli ROSETTA (DE3) cells (Novagen) with
TEV-cleavable N-terminal GST and a noncleavable C-ter-
minal His6-tag. The recombinant proteins were purified
using Ni2+ and GST affinity purification. The quality of the
kinase domains was checked by SDS/PAGE analysis. FP
measurements were performed without cleavage of the
GST-tag.
Expression and purification of recombinant
peptides
The peptides FOR20 (1–48), FOP (1–48), p53 (1–60; 17–
53), NMIIA (1894–1937), C-ERMAD (516–560 and 516–
586), and RSK1 (696–735 and 689–735) were expressed in
E. coli BL21 (DE3) cells (Novagen) with TEV-cleavable N-
terminal GST-tag, and purified by GST affinity chromatog-
raphy. The tag was cleaved by TEV protease. After cleav-
age, the TEV protease and GST-tag were eliminated by
heat denaturation and centrifugation. The supernatant was
purified by RP-HPLC using a Jupiter 300 A C5 column
(Phenomenex, Torrance, CA, USA). The quality of the
expressed peptides was checked by mass spectrometry (Bru-
ker Daltonics, Billerica, MA, USA).
Peptide synthesis
The CapZ (265–276), NCX1 (254–265), SIP (188–202),
TRPM4 (129–147), and MDM4 (25–43) peptides were
chemically synthesized using solid-phase peptide synthesis
with a PS3 peptide synthesizer (Protein Technologies, Tuc-
son, AZ, USA) with Fmoc/tBu strategy in the case of 5(6)-
carboxyfluorescein-labeled and 5(6)-carboxyfluorescein-un-
labeled version. Peptides were purified by RP-HPLC using
a Jupiter 300 A C18 column (Phenomenex). The quality of
the peptides was monitored by HPLC-MS (Agilent, Santa
Clara, CA, USA).
Determination of concentrations
Concentrations of peptides and proteins were determined
by UV spectrophotometry using the absorbance of Tyr and
Trp residues. In the absence of these aromatic residues, the
concentrations were calculated by using the absorbance of
the compound on 205 and 214 nm [49,50].
Fluorescent labeling
Chemically synthesized peptides (CapZ, NCX1, SIP,
TRPM4, and MDM4) were labeled with 5(6)-carboxyfluo-
rescein (Sigma-Aldrich, St. Louis, MO, USA) at the N ter-
minus at the end of the synthesis. The recombinant
peptides (p53, NMIIA, and RSK1) were labeled with fluo-
rescein isothiocyanate (Sigma-Aldrich) at an N-terminal
Cys residue using the protocol described previously [48]. C-
ERMAD was labeled by Alexa Fluor 568 C5 maleimide
(Molecular Probes, Eugene, OR, USA) [19]. The excess
labeling agent was eliminated by using HiTrap Desalting
column (GE Healthcare, Little Chalfont, UK). The labeled
peptides were further purified and separated from the unla-
beled peptides by RP-HPLC using a Jupiter 300 A C5 col-
umn (Phenomenex). The concentration of fluorescent
peptides and the efficiency of labeling were determined by
measuring the absorbance of the fluorescent dye and the
peptides.
FP measurements
Fluorescence polarization was measured with a Synergy H4
plate reader (BioTek Instruments, Winooski, VT, USA) by
using 485  20 nm and 528  20 nm, and 530  25 nm
and 590  35 nm band-pass filters (for excitation and emis-
sion, respectively) in cases of fluorescein-based (former)
and Alexa Fluor 568-based (latter) measurements. In direct
FP measurements, a dilution series of the S100 protein was
prepared in 96-well plates (96-well skirted pcr plate, 4ti-
0740; 4titude, Wotton, UK) in a buffer that contained
150 mM NaCl, 20 mM HEPES pH 7.5, 1 mM CaCl2,
0.5 mM TCEP, 0,01% Tween-20, and 50-nM fluorescent-la-
beled peptide (probe). The volume of the dilution series
was 50 µL, which was later divided into three technical
replicates of 15 µL during transferring to 384-well micro-
plates (low binding microplate, 384 well, E18063G5; Grei-
ner Bio-One, Kremsm€unster, Austria). In total, the
polarization of the probe was measured at eight different
S100 concentrations (whereas one contains no S100 protein
and corresponds to the free peptide). In competitive FP
measurements, the same buffer was supplemented with
S100 proteins to achieve a complex formation of 60–80%,
based on the titration. Then, this mixture was used for cre-
ating a dilution series of the competitor (e.g., unlabeled
peptide or purified protein) and the measurement was car-
ried out identically as in the direct experiment. Competitive
FP measurement was executed if the fitted Kd value origi-
nated from the direct FP titration was below 200 µM.
Table 3 shows the peptides used for direct and competitive
FP measurements. The typical experimental window of an
S100 interaction was found to be around 100 mP (polariza-
tion). However, some direct titration caused marginally
small change in the polarization signal (10–30 mP) that we
decided not to analyze further.
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Fitting of FP data
The Kd of the direct and competitive FP experiment was
obtained by fitting the measured data with quadratic and
competitive equation, respectively [7]. For automatic fitting,
we used an in-house developed, Python-based program,
called ProFit, which is freely available from GitHub. The
program is capable to process multiple experimental data
at once, evaluate direct competitive experimental data series
pairs, and estimate the variance of the deduced parameters
(e.g., dissociation constants) through a Monte Carlo
approach. It produces ready-to-use figures for publications,
as well as a report sheet for evaluation.
ITC measurements
Titrations were carried out either at 310 or at 298 K in a
buffer containing 150 mM NaCl, 20 mM HEPES pH 7.5,
1 mM CaCl2, 0.5 mM TCEP, using a MicroCal PEAQ-ITC
instrument (Malvern Panalytical, Malvern, UK). The
acquired data were fitted by PEAQ-ITC analysis software
using the model ‘One Set of Sites’ for most of the experi-
ments; however for S100B-CapZ and S100B-MDM4, this
model provided unsatisfactory fits and the model ‘Two Sets
of Sites’ were applied instead. Note that we used the mini-
mal interacting region (696–735) of RSK1 instead of the
larger construct (689–735), which was used in the direct FP
assay.
Bioinformatics analysis
For the phylogenetic analysis, the human S100 protein
sequences were aligned using CLUSTALW [29] (gap open pen-
alty 10 and gap extension penalty 0.1 for pairwise align-
ment; gap open penalty 10 and gap extension penalty 0.2
for multiple sequence alignment, BLOSUM weight matrix),
MUSCLE [51], and PRANK [51] algorithms. Gaps were replaced
by ambiguous residues (question marks) before the begin-
ning and after the end of each sequence in the raw
sequence alignment to avoid the overinterpretation of the
highly variant tail extensions in the further analysis. Phy-
logeny was conducted with RAXML GUI [52]. Evolutionary
history was inferred using maximum-likelihood algorithm
with ProtGamma and LG as substitution model and substi-
tution matrix, respectively [53], with 10 runs and 1000
bootstrap replicates. For the mapping of functional
Table 3. Peptides used in this study.
Name Region Sequence Modification
fp53 p53 (17–56) GSCETFSDLWKLLPENNVLSPLPSQAMD
DLMLSPDDIEQWFTE
Fluorescein isothiocyanate
fRSK1 RSK1 (689–735) GSCQDLQLVKGAMAATYSALNSSKPTPQL
KPIESSILAQRRVRKLPSTTL
Fluorescein isothiocyanate
fNMIIA NMIIA (1894–1937) CRKLQRELEDATETADAMNREVSSLKNKL
RRGDLPFVVPRRMARK
Fluorescein isothiocyanate
fMDM4 MDM4 (25–43) NQVRPKLPLLKILHAAGAQ N-terminal carboxyfluorescein
fCapZ CapZ (265–276) TRTKIDWNKILS N-terminal carboxyfluorescein
fNCX1 NCX1 (254–265) RRLLFYKYVYKR N-terminal carboxyfluorescein
fTRPM4 TRPM4 (129–147) VLQTWLQDLLRRGLVRAAQ N-terminal carboxyfluorescein
fSIP SIP (188–202) SEGLMNVLKKIYEDG N-terminal carboxyfluorescein
fC-ERMAD C-ERMAD (516–560) GSCKRITEAEKNERVQRQLLTLSSELSQAR
DENKRTHNDIIHNENMRQG
Alexa Fluor 568 C5 maleimide
p53 p53 (1–60) GSMEEPQSDPSVEPPLSQETFSDLWKLLPEN
NVLSPLPSQAMDDLMLSPDDIEQWFTEDPGP
None (free N and C terminus)
NMIIA NMIIA (1894–1937) YRKLQRELEDATETADAMNREVSSLKNKLR
RGDLPFVVPRRMARK
None (free N and C terminus)
MDM4 MDM4 (25–43) NQVRPKLPLLKILHAAGAQ None (free N and C terminus)
CapZ CapZ (265–276) TRTKIDWNKILS None (free N and C terminus)
NCX1 NCX1 (254–265) RRLLFYKYVYKR None (free N and C terminus)
TRPM4 TRPM4 (129–147) VLQTWLQDLLRRGLVRAAQ None (free N and C terminus)
SIP SIP (188–202) SEGLMNVLKKIYEDG None (free N and C terminus)
C-ERMAD C-ERMAD (516–586) GSCKRITEAEKNERVQRQLLTLSSELSQARD
ENKRTHNDIIHNENMRQGRDKYKTLRQIRQ
GNTKQRIDEFEAL
None (free N and C terminus)
FOR20 FOR20 (1–48) GSMATVAELKAVLKDTLEKKGVLGHLKARIR
AEVFNALDDDREPRPSLSH
None (free N and C terminus)
FOP FOP (1–48) GSYAATAAAVVAEEDTELRDLLVQTLENSGVL
NRIKAELRAAVFLALEEQ
None (free N and C terminus)
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relationships and clustering, the dendrogram from the
S100ome data set was constructed using the unweighted
pair-group method with arithmetic average (UPGMA)
method [32] based on the Euclidean distance using the
PAST software [54].
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